CBAS AI app monitors patient movements

The CBAS team hard at work

Artificial intelligence is being used to analyse the physical movements of patients in a bid to help doctors make better decisions.

Tech Corridor firm Cambridge Bio-Augmentation Systems (CBAS) is leading a consortium to develop an AI platform which will map patients’ movements on a daily basis. The project is being backed by an £865,000 Innovate UK grant.

The solution will apply to a wide range of conditions and help clinicians make data-informed decisions about patient progress and wellbeing.

Partnering CBAS in the consortium are Andiamo, which makes user-centred children’s orthotics – devices which aid walking for patients with limited mobility – CUSH Health, which develops smart devices for elderly patients, and the Human Performance Lab at Queen Mary University of London.

CBAS co-founders Oliver Armitage, left, and Emil Hewage

Oliver Armitage, co-founder and chief scientific officer at CBAS said: “We are so pleased to be taking our AI platform to the next stage and trying it with real patients in the field. Having the support and validation of Innovate UK shows the appetite for AI solutions in healthcare, and the enthusiasm of our partners shows the willingness of the industry to begin incorporating these types of solutions into their products.”

CBAS has developed the AI platform and will be trialling it with Andiamo’s 3D printed orthoses and CUSH Health’s smart device for elderly patients at risk of falls. The project is beginning this month and will continue for 15 months. Groups of patients will be selected to trial wearable devices on their orthoses and devices in their daily lives over a few months and the readings analysed by the AI platform will then be validated by Queen Mary’s Human Performance.

The Human Performance Lab in addition to validating test results from the AI analysis, which so far has been shown to be 96 per cent accurate, will explore how to apply the novel technology to movement measurements. The ultimate aim for a finished product is to help clinicians deliver better care as well as add greater insight and support for their patients and their families.

Naveed Parvez, co-founder and CEO at Andiamo said, “We’re very excited to be collaborating with CBAS on this project. It is clear to us that the future of healthcare will and must be driven by outcomes and evidence. Orthotic users want to better understand their condition and their journey to an outcome, clinicians want to deliver evidence-based practice, and providers want to understand what is ‘good’. The support from Innovate UK will drive this critical change faster, and allow us to understand how healthcare will adopt a move to a much greater transparency in orthotic treatments.”

Kalon Hewage, co-founder of CUSH Health said: “My co-founder, Dr Sam Fosker, and I are delighted to once again have the backing of Innovate UK for our solution to combat the epidemic of falls in the elderly. As a new company this is an amazing opportunity to validate our solution while working with incredibly talented and respected partners. As a practising surgeon I see first hand the effect that falls have on patients and their families and this is even more worrying with the current healthcare model stretched to breaking point. Healthcare innovation, however, offers the opportunity to decrease falls-related morbidity and mortality while also decreasing A&E attendances and acute hospital admissions.”

Dr Aleksandra Birn-Jeffery, lecturer in bioengineering, Queen Mary University of London, added: “Not only is it an exciting opportunity to validate new technology that could make such a difference to patient care pathways, but we will be working alongside some incredible companies that are all striving to improve healthcare. This grant also provides the chance to start delving into understanding how we can define whether an individual’s movement pattern is improving to potentially, in the future, further improve patient gait assessment.”

A spin-out from Cambridge University, CBAS is creating software and hardware that can interface with the body to help support the next generation of bionic and neural treatments, such as advanced artificial limbs for amputees.

*The Cambridge Norwich Tech Corridor is seeking to foster links and promote outstanding medtech companies in the region. To find out how your firm can’t get involved with the initiative, drop us a line.